- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Carbuterol is a type of respiratory drug used to treat asthma and other breathing disorders. It is a short-acting beta-2 agonist, meaning it works by relaxing the muscles of the airways, allowing more air to flow through. Carbuterol is available in both inhaler and tablet form, and is often used in combination with other medications. It is generally considered to be a safe and effective treatment for asthma and other breathing disorders.
Carbuterol is widely used in the treatment of asthma and other respiratory diseases, and is available in many countries around the world. It is often prescribed as a first-line treatment for asthma, and is also used to treat other conditions such as chronic obstructive pulmonary disease (COPD).
The Carbuterol market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more